We have moved on from talking about the BNF. I accept the comments about listing groups that would be considered in new clause 5. Does the Minister accept, however, that we still need to deal with the cascade of prescribing to ensure doctors are not forced to prescribe a licensed medicine, which is actually just a minimal moderation of an off-patent drug at a vastly expensive cost? That means we still need some kind of change to the licensing or short licensing process in the future.
Access To Medical Treatments (Innovation) Bill
Proceeding contribution from
Philippa Whitford
(Scottish National Party)
in the House of Commons on Friday, 29 January 2016.
It occurred during Debate on bills on Access To Medical Treatments (Innovation) Bill.
About this proceeding contribution
Reference
605 c546 Session
2015-16Chamber / Committee
House of Commons chamberSubjects
Librarians' tools
Timestamp
2021-11-04 13:29:53 +0000
URI
http://hansard.intranet.data.parliament.uk/Commons/2016-01-29/16012937000142
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2016-01-29/16012937000142
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2016-01-29/16012937000142